MY143679A - 15b-subsitituded streoids having selective estrogenic activity - Google Patents

15b-subsitituded streoids having selective estrogenic activity

Info

Publication number
MY143679A
MY143679A MYPI20054157A MYPI20054157A MY143679A MY 143679 A MY143679 A MY 143679A MY PI20054157 A MYPI20054157 A MY PI20054157A MY PI20054157 A MYPI20054157 A MY PI20054157A MY 143679 A MY143679 A MY 143679A
Authority
MY
Malaysia
Prior art keywords
subsitituded
streoids
estrogenic activity
5alkyl
selective estrogenic
Prior art date
Application number
MYPI20054157A
Inventor
Hubert Jan Jozef Loozen
Antonius Gerardus Hendykus Ederveen
Freddericus Antonius Dijcks
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MY143679A publication Critical patent/MY143679A/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Steroid Compounds (AREA)

Abstract

1 8 150-SUBSTITUTED STEROIDS HAVING SELECTIVE ESTROGENIC ACTIVITY 5 ABSTRACT THE INVENTION PROVIDES 15P-SUBSTITUTED STEROIDAL COMPOUNDS HAVING SELECTIVE ESTROGEN RECEPTOR ACTIVITY ACCORDING TO FORMULA L OR 4 H R3 10 R 0 R WHEREIN. R1 IS H, CI-5ALKYL. CI-12ACYL, DI-(C1-5ALKYL)AMINOCARBONYL, (CI-5ALKYL)OXYCARBONYL OR 15 SULFAMOYL, R 2IS H. CI 3 ALKYL, C23ALKENYL ORC2-3 ALKYNYL, EACH OF WHICH MAY BE OPTIONALLY SUBSTITUTED WITH A HALOGEN, R3 IS CI-2 ALKYL, ETHENYL OR ETHYNYL, EACH OF WHICH MAY BE OPTIONALLYSLIBSTITUTED WITH A HALOGEN, AND 20 R' IS H OR C1,12 ACYL D CFO Q 1@.-
MYPI20054157A 2004-09-08 2005-09-05 15b-subsitituded streoids having selective estrogenic activity MY143679A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04043340 2004-09-08

Publications (1)

Publication Number Publication Date
MY143679A true MY143679A (en) 2011-06-30

Family

ID=45023972

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20054157A MY143679A (en) 2004-09-08 2005-09-05 15b-subsitituded streoids having selective estrogenic activity

Country Status (1)

Country Link
MY (1) MY143679A (en)

Similar Documents

Publication Publication Date Title
TW200621795A (en) 15β-substituted steroids having selective estrogenic activity
NZ561747A (en) (Pyrrol-2-ylmethyl)-indol-1-yl-acetic acid derivatives with PGD2 antagonist activity
MXPA06001592A (en) (4-hydroxyphenyl)-1h-indole-3-carbaldehyde oxime derivative as estrogenic agents.
WO2006135638A3 (en) Tanaproget compositions containing ethinyl estradiol
BR112021024033A2 (en) Neuroactive steroids and their compositions
WO2008126889A1 (en) Hydrazide compound and harmful arthropod-controlling agent containing the same
BR9714510A (en) Process and preparation of 9,11-epoxy steroids and useful intermediates
ATE393764T1 (en) POLYMORPHOUS FORMS OF VALSARTAN
WO2009038064A1 (en) Heterocyclic derivative having inhibitory activity on type-i 11β-hydroxysteroid dehydrogenase
NO20071922L (en) Indazoles, benzisocazoles and benzinsothiazoles and their use as estrogenic agents
TW200605880A (en) Progesterone receptor antagonist contraceptive regimens and kits
WO2005077968A8 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
AU2003304425A8 (en) Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
MX2009008756A (en) Macrocyclic compound.
WO2008111632A1 (en) Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative
HRP20110161T1 (en) 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same
DE50308933D1 (en) COMPOSITION, CONTAINING AN ANDROGENIC 11-B HALOGEN STEROIDE AND A STATEMENT AND MALE CONTRAZEPTIVUM BASED ON THIS COMPOSITION
DE602004026558D1 (en) SELECTIVE NON-TTEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS
EP1655291A4 (en) Compounds having thrombopoietin receptor agonism
MY143679A (en) 15b-subsitituded streoids having selective estrogenic activity
AU2003285652A1 (en) Eaf side wall panel to provide for primary and secondary combustion as well as particel injection at the same time, and operating method therefor
MX2008011292A (en) Steroidal compounds as steroid sulphatase inhibitors.
ATE303397T1 (en) 9-ALPHA-SUBSTITUTED ESTRATRIENES AS SELECTIVELY EFFECTIVE ESTROGENS
ATE277071T1 (en) STEROIDS SUBSTITUTED BY 11-BETA-ARYL-17,17-SPIROTHIOLANE
TW200506005A (en) Use of quinaldine and naphthalene derivatives as crystallization modifiers